Infectious Disease
(Physicians) – Optimizing Influenza Immunization for Older Adults
Individuals aged 65 years and older are at an increased risk for more detrimental effects of influenza. This program helps clinicians optimize influenza immunization for adults aged ≥65 years old. The program will review the influenza burden in this population, the types of adverse outcomes experienced by older adults, and how to prevent adverse outcomes with vaccination. Using a case study, the program will also compare the different vaccines indicated for this population and discuss the National Advisory Committee on Immunization (NACI) and Advisory Committee on Immunization Practices (ACIP) recommendations as well as the available real-world vaccine effectiveness data for influenza vaccines in adults ≥65 years old.
DURATION
30 min
PROFESSION
Physician
# OF CREDITS
0.5
ACCREDITATION
Mainpro+
EXPIRY DATE
2023-12-31
Individuals aged 65 years and older are at an increased risk for more detrimental effects of influenza.
This program helps clinicians optimize influenza immunization for adults aged ≥65 years old. The program will review the influenza burden in this population, the types of adverse outcomes experienced by older adults, and how to prevent adverse outcomes with vaccination.
Using a case study, the program will also compare the different vaccines indicated for this population and discuss the National Advisory Committee on Immunization (NACI) and Advisory Committee on Immunization Practices (ACIP) recommendations as well as the available real-world vaccine effectiveness data for influenza vaccines in adults ≥65 years old.
This program is made possible through educational support from CSL Seqirus.
Faculty
Melissa Andrew, MD, MSc Public Health, PhD, FRCPC
Anas Nseir, MD
Shelley Ross, MD
Sofia Nastis, MD, CCFP
Stephane Villeneuve, Pharm. D.
Carlene Oleskyn, B.S.P., R.Ph, CTH, CDE
Learning objectives
- Discuss the burden of influenza in adults ≥65 years old.
- Review the strains that cause the most influenza in adults ≥65 years old.
- Compare the influenza vaccines indicated for adults ≥65 years old and discuss NACI and ACIP recommendations for this population.
- Describe the available Real World Vaccine Effectiveness data for influenza vaccines in adults ≥65 years old.
Accreditation
Cert+ Program ID#: 198387